SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000928464-20-000032
Filing Date
2020-08-07
Accepted
2020-08-07 21:45:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 enzonsc13da08072020.htm SC 13D/A 8879
  Complete submission text file 0000928464-20-000032.txt   10910
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Subject) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-35587 | Film No.: 201086835
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ICAHN ENTERPRISES L.P. 16690 COLLINS AVE., PH-1 SUNNY ISLES BEACH FL 33160
Business Address C/O ICAHN ENTERPRISES L.P. 16690 COLLINS AVE., PH-1 SUNNY ISLES BEACH FL 33160 305-422-4145
ICAHN CARL C (Filed by) CIK: 0000921669 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 0000